CN103816233A - Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo - Google Patents
Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo Download PDFInfo
- Publication number
- CN103816233A CN103816233A CN201410046850.5A CN201410046850A CN103816233A CN 103816233 A CN103816233 A CN 103816233A CN 201410046850 A CN201410046850 A CN 201410046850A CN 103816233 A CN103816233 A CN 103816233A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitiligo
- externally
- traditional chinese
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an externally-used traditional Chinese medicinal composition for treating incomplete vitiligo, and relates to the technical field of medicines. The externally-used traditional Chinese medicinal composition comprises the following components in parts by weight: 15-26 parts of fructus psoraleae, 10-15 parts of vernonia anthelmintica, 5-10 parts of polygonum multiflorum, 5-10 parts of radix angelicae, 5-10 parts of Chinese parsnip root, 3-12 parts of lithargite and 4-10 parts of sulphur. The externally-used traditional Chinese medicinal composition is reasonable in composition and good in therapeutic effect on the incomplete vitiligo; through external use, the externally-used traditional Chinese medicinal composition can eliminate wind toxicity, nourish blood, increase the permeability of skin, stimulate resurrection and regeneration of melanocytes, consolidate superficial resistance, dispel wind, tonify kidney and consolidate vital energy.
Description
Technical field
The present invention relates to medical technical field, be specifically related to a kind of external medicine composition for the treatment of vitiligo imperfection white macula.
Background technology
Vitiligo (vitiligo) point completeness white macula and two types of imperfection white macula.It is a kind of common multiple pigmented dermatosis.This disease forms white macula as feature take local or general property depigmentation, is a kind of acquired limitation or general property depigmentation of skin, is the common skin diseases of an impact beauty treatment, easily diagnosis, and treatment is difficult.Traditional Chinese medical science medical science is referred to as " vitiligo " or " vitiligo ".Vitiligo is that posteriority is lost the limitation white patch occurring because skin pigment is de-, makes local skin be white macula sample.Medically conventionally this pathological changes depigmentation.This disease all has generation all over the world, and India's sickness rate is the highest, and China approximately has tens of millions of people to fall ill, and can involve all races, and men and women falls ill without marked difference.
The traditional Chinese medical science is thought, lung governing qi, main white.White macula is due to insufficiency of vital energy and blood, makes the skin must not nutrition and bleach.Leukodermic morbidity is the synergistic result of body internal and external factor, in because liver spleen suffer from a deficiency of the kidney, how by deficiency of liver-blood, insufficiency of kidney-YANG, deficiency of kidney-QI, cause and make body yin and yang imbalance, qi-blood disharmony, damp and hot ailment said due to cold or exposure is taken advantage of a weak point on this basis, and visitor enters skin, impatency meridians blood vessels, skin must not be warm, and skin and hair loses to support and causes incontinentia pigmentosa achromians and form white macula.Traditional Chinese medical science curing vitiligo adopts QI and blood regulating, Shugan Bushen more, the method for dispelling wind and removing obstruction in the collateral.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of combination simple, the external medicine composition of eutherapeutic treatment vitiligo imperfection white macula.
Technical problem to be solved by this invention realizes by the following technical solutions:
Treat an external medicine composition for vitiligo imperfection white macula, formed by following parts by weight of component,
Fructus Psoraleae 15-26 part, Caulis Vernoniae andersonii 10-15 part, Radix Polygoni Multiflori 5-10 part, Radix Angelicae Dahuricae 5-10 part, Radix Saposhnikoviae 5-10 part, Lithargyrum 3-12 part, sulfur 4-10 part.
The better ratio of weight and number of above-mentioned each taste medicine is:
Fructus Psoraleae 18-22 part, Caulis Vernoniae andersonii 13-15 part, Radix Polygoni Multiflori 7-9 part, Radix Angelicae Dahuricae 7-9 part, Radix Saposhnikoviae 5-7 part, Lithargyrum 9-11 part, sulfur 7-9 part.
The optimum weight portion rate of above-mentioned each taste medicine is:
20 parts of Fructus Psoraleaes, 15 parts of Caulis Vernoniae andersoniis, 8 parts of Radix Polygoni Multiflori, 8 parts of the Radixs Angelicae Dahuricae, 6 parts of Radix Saposhnikoviaes, 10 parts of Lithargyrums, 8 parts, sulfur.
Each taste medicine in above-mentioned Recipe of external-use medicine is mixed in proportion, grinds to form fine powder for subsequent use.
Usage: with fresh ginger slice, be cut into the long section shape of 3～4cm by Rhizoma Zingiberis Recens, dip in medicated powder and embrocate affected part, friction gently, treat white macula slight rubescent till, morning, noon and afternoon every day 3 times, 90 days per courses for the treatment of.
Clinical observation: normally use 3-7 days white maculas to redden, white macula edge forms in white and black border, progressively tends towards stability, and area no longer expands, after 30 days, white macula is no longer new, and white macula position has thickly dotted black vegetarian refreshments to produce.About 4-6 month, the white macula of general coin-size can rehabilitation, and about 6-8 month, egg size white macula can rehabilitation, and about 10-12 month, the large white macula of palm can rehabilitation.
In medical material provided by the present invention:
Fructus Psoraleae: pungent, bitter, temperature.Return kidney, spleen channel.Function with cure mainly: warming the kidney to activate YANG, improving inspiration by invigorating kidney-QI, antidiarrheal.For impotence and seminal emission, enuresis frequent micturition, chills and pain of the waist and kness, suffers from a deficiency of the kidney and breathes heavily, Diarrhoea; External curing vitiligo, alopecia areata.
Caulis Vernoniae andersonii: fruit, bitter in the mouth, cool in nature.Function with cure mainly: heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, parasite killing treat tinea.Be used for the treatment of skin wrinkle, anthelmintic.It is the topmost medical material of Uygur medicine treatment leukoderma.
Radix Polygoni Multiflori: Radix Polygoni Multiflori Preparata is sweet, puckery, tepor; Return liver, kidney channel.Radix Polygoni Multiflori is sweet, bitter, flat; GUIXIN, liver, large intestine channel.Radix Polygoni Multiflori Preparata tonification menses, black hair reinforces the kidney; Radix Polygoni Multiflori cuts cruel removing toxic substances, loosening bowel to relieve constipation.
The Radix Angelicae Dahuricae: pungent, temperature.Attach to the lung and stomach meridians.The loose wind that induces sweat, sensible, pain relieving, dampness leukorrhagia stopping, detumescence and apocenosis.
Radix Saposhnikoviae: pungent, sweet, tepor.Return bladder, liver, spleen channel.Deliver loose wind, removing dampness to relieve pain, relieving convulsion, antidiarrheal.
Sulfur: acid, temperature.Poisonous.Return kidney, large intestine channel.Effect: external removing toxic substances parasite killing is treated skin ulcer; The fiery supporing yang relieving constipation of benefit for oral administration.
Lithargyrum: salty, pungent, flat, poisonous; Return liver, spleen channel.Function cures mainly: dampness, and parasite killing, convergence, anticorrosion, removing toxic substances.Main skin infection fester do not restrain for a long time, aphtha, scabies, bromhidrosis, tinea versicolor, (black dry) are dim, wine Zha nose, burn and scald, eczema.
All medicines in external side: deintoxication, and nutrient blood, increase cutaneous permeability, stimulate melanocyte nucleus formation.Treatment vitiligo imperfection white macula has good curative effect.
The present invention, by Caulis Vernoniae andersonii and sulfur and the same use of Radix Polygoni Multiflori, has changed the mode of tradition as oral medicine, is prepared into liniment, has improved drug effect, and powder is easy to preserve, and it is also convenient to use.
Clinical experiment
1, case source
Choose 550 routine patients with vitiligo at the each large Dermatology of this city, topical type in patient, distribute type, acra type, general hair style, segmental pattern and all have.Wherein male's 240 examples, women's 310 examples, the course of disease is between half a year to 8 year, and average course of disease is 3.23, and patient age is between 8-50 year.
2, test method
Patient uses medicine wiping affected part of the present invention, and every day 4 times, each 2 times sooner or later, every minor tick 30 minutes, uses 3 months continuously.
3, criterion of therapeutical effect
Effective: white macula disappears completely or white macula area reducing is greater than 70%;
Effective: white macula area reducing, white macula area reducing is greater than 50%;
Invalid: the unchanged or white macula area reducing of white macula is less than 10%.
4, therapeutic outcome
| Number of cases | Effective | Effectively | Invalid | Effective percentage (%) |
| 550 | 252 | 290 | 8 | 98 |
The invention has the beneficial effects as follows: compatibility of the present invention is reasonable, good to vitiligo imperfection white macula therapeutic effect, this medicine adopts the mode of external treatment, external side's deintoxication, and nutrient blood, increase cutaneous permeability, stimulate melanocyte to bring back to life, become again, can consolidating superficial resistance dispel the wind, reinforcing kidney and strengthening resistance and nutrient blood, treatment vitiligo imperfection white macula has good curative effect.
The specific embodiment
For technological means, creation characteristic that the present invention is realized, reach object and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
Treat an external medicine composition for vitiligo imperfection white macula, formed by following parts by weight of component: 26 parts of Fructus Psoraleaes, 15 parts of Caulis Vernoniae andersoniis, 10 parts of Radix Polygoni Multiflori, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Saposhnikoviaes, 12 parts of Lithargyrums, 10 parts, sulfur.Each taste medicine in above-mentioned Recipe of external-use medicine is mixed in proportion, grinds to form fine powder for subsequent use.Usage: with fresh ginger slice, be cut into the long section shape of 3～4cm by Rhizoma Zingiberis Recens, dip in medicated powder and embrocate affected part, friction gently, treat white macula slight rubescent till, every day each 2 times sooner or later, 30 minutes, interval between 2 times, 90 days per courses for the treatment of.
Embodiment 2
Treat an external medicine composition for vitiligo imperfection white macula, formed by following parts by weight of component: 15 parts of Fructus Psoraleaes, 10 parts of Caulis Vernoniae andersoniis, 5 parts of Radix Polygoni Multiflori, 5 parts of the Radixs Angelicae Dahuricae, 5 parts of Radix Saposhnikoviaes, 3 parts of Lithargyrums, 4 parts, sulfur.Each taste medicine in above-mentioned Recipe of external-use medicine is mixed in proportion, grinds to form fine powder for subsequent use.Usage: with fresh ginger slice, be cut into the long section shape of 3～4cm by Rhizoma Zingiberis Recens, dip in medicated powder and embrocate affected part, friction gently, treat white macula slight rubescent till, every day each 2 times sooner or later, 30 minutes, interval between 2 times, 90 days per courses for the treatment of.
Embodiment 3
Treat an external medicine composition for vitiligo imperfection white macula, formed by following parts by weight of component: 20 parts of Fructus Psoraleaes, 15 parts of Caulis Vernoniae andersoniis, 8 parts of Radix Polygoni Multiflori, 8 parts of the Radixs Angelicae Dahuricae, 6 parts of Radix Saposhnikoviaes, 10 parts of Lithargyrums, 8 parts, sulfur.Each taste medicine in above-mentioned Recipe of external-use medicine is mixed in proportion, grinds to form fine powder for subsequent use.Usage: with fresh ginger slice, be cut into the long section shape of 3～4cm by Rhizoma Zingiberis Recens, dip in medicated powder and embrocate affected part, friction gently, treat white macula slight rubescent till, every day each 2 times sooner or later, 30 minutes, interval between 2 times, 90 days per courses for the treatment of.
Embodiment 4
Treat an external medicine composition for vitiligo imperfection white macula, formed by following parts by weight of component: 21 parts of Fructus Psoraleaes, 13 parts of Caulis Vernoniae andersoniis, 9 parts of Radix Polygoni Multiflori, 9 parts of the Radixs Angelicae Dahuricae, 7 parts of Radix Saposhnikoviaes, 11 parts of Lithargyrums, 9 parts, sulfur.Each taste medicine in above-mentioned Recipe of external-use medicine is mixed in proportion, grinds to form fine powder for subsequent use.Usage: with fresh ginger slice, be cut into the long section shape of 3～4cm by Rhizoma Zingiberis Recens, dip in medicated powder and embrocate affected part, friction gently, treat white macula slight rubescent till, every day each 2 times sooner or later, 30 minutes, interval between 2 times, 90 days per courses for the treatment of.
Embodiment 5
Treat an external medicine composition for vitiligo imperfection white macula, formed by following parts by weight of component: Fructus Psoraleae 19g, Caulis Vernoniae andersonii 14g, Radix Polygoni Multiflori 7g, Radix Angelicae Dahuricae 7g, Radix Saposhnikoviae 5g, Lithargyrum 9g, 7 parts of g of sulfur.Each taste medicine in above-mentioned Recipe of external-use medicine is mixed in proportion, grinds to form fine powder for subsequent use.Usage: with fresh ginger slice, be cut into the long section shape of 3～4cm by Rhizoma Zingiberis Recens, dip in medicated powder and embrocate affected part, friction gently, treat white macula slight rubescent till, every day each 2 times sooner or later, 30 minutes, interval between 2 times, 90 days per courses for the treatment of.
Model case
Case one: Bao so-and-so, 8 years old, man, people from Huoqiu County, Anhui Province, goes to school in Wuxi City, Jiangsu Province with father and mother.The first visit time is on March 14th, 2010, diseased region outside the corners of the mouth of left side above, left index finger metacarpophalangeal joint, with Drug therapy of the present invention half a year, cures, and follows up a case by regular visits to not recurrence in a year.
Case two: fourth, female, 24 years old, graduate from university, the Yancheng City people of Jiangsu Province.The first visit time is on August 15th, 2010, and diseased region is whole scalp, face, chest, abdominal part, uses the embodiment of the present invention 3 Drug therapy 10 months, therapeutic outcome recovery from illness.
Case three: turn round and look at so-and-so, man, 8 years old, March 13 2010 first visit time, Shanghai people, site of pathological change women's head-ornaments, extremity, back, buttocks, use the embodiment of the present invention 4 Drug therapy 7 months, therapeutic outcome recovery from illness.
Case four: Wang, female, 19 years old, April 9 2011 first visit time, people from Funan County, Anhui Province, site of pathological change shoulder, arm, hands, lower abdomen, huckle, use the embodiment of the present invention 5 Drug therapy 8 months, therapeutic outcome recovery from illness.
More than show and described ultimate principle of the present invention and principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; that in above-described embodiment and description, describes just illustrates principle of the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.
Claims (3)
1. an external medicine composition for the treatment of vitiligo imperfection white macula, is characterized in that: formed by following parts by weight of component,
Fructus Psoraleae 15-26 part, Caulis Vernoniae andersonii 10-15 part, Radix Polygoni Multiflori 5-10 part, Radix Angelicae Dahuricae 5-10 part, Radix Saposhnikoviae 5-10 part, Lithargyrum 3-12 part, sulfur 4-10 part.
2. a kind of external medicine composition for the treatment of vitiligo imperfection white macula according to claim 1, is characterized in that: formed by following parts by weight of component,
Fructus Psoraleae 18-22 part, Caulis Vernoniae andersonii 13-15 part, Radix Polygoni Multiflori 7-9 part, Radix Angelicae Dahuricae 7-9 part, Radix Saposhnikoviae 5-7 part, Lithargyrum 9-11 part, sulfur 7-9 part.
3. one according to claim 2 is used for the treatment of leukodermic outer liniment, it is characterized in that: formed by following parts by weight of component,
20 parts of Fructus Psoraleaes, 15 parts of Caulis Vernoniae andersoniis, 8 parts of Radix Polygoni Multiflori, 8 parts of the Radixs Angelicae Dahuricae, 6 parts of Radix Saposhnikoviaes, 10 parts of Lithargyrums, 8 parts, sulfur.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046850.5A CN103816233A (en) | 2014-02-10 | 2014-02-10 | Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046850.5A CN103816233A (en) | 2014-02-10 | 2014-02-10 | Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103816233A true CN103816233A (en) | 2014-05-28 |
Family
ID=50751714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410046850.5A Pending CN103816233A (en) | 2014-02-10 | 2014-02-10 | Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103816233A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958466A (en) * | 2015-08-05 | 2015-10-07 | 王凯琳 | Medicine for treating vitiligo |
| CN110339257A (en) * | 2019-08-20 | 2019-10-18 | 江苏博润医疗集团有限公司 | It is a kind of for treating the external drug of leucoderma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101190270A (en) * | 2007-04-29 | 2008-06-04 | 李明君 | Both oral and external traditional Chinese medicinal powder preparation for synthetically treating leukoderma |
| CN101234162A (en) * | 2007-12-21 | 2008-08-06 | 汤铁强 | Chinese medicine formula for treating leukoderma and preparation thereof |
| CN102755417A (en) * | 2012-06-28 | 2012-10-31 | 固镇县中医院 | External medicinal liquid for treating vitiligo |
-
2014
- 2014-02-10 CN CN201410046850.5A patent/CN103816233A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101190270A (en) * | 2007-04-29 | 2008-06-04 | 李明君 | Both oral and external traditional Chinese medicinal powder preparation for synthetically treating leukoderma |
| CN101234162A (en) * | 2007-12-21 | 2008-08-06 | 汤铁强 | Chinese medicine formula for treating leukoderma and preparation thereof |
| CN102755417A (en) * | 2012-06-28 | 2012-10-31 | 固镇县中医院 | External medicinal liquid for treating vitiligo |
Non-Patent Citations (1)
| Title |
|---|
| 王毅侠等: "白癜风的中西医药物治疗", 《空军总医院学报》, vol. 23, no. 04, 31 December 2007 (2007-12-31), pages 218 - 226 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958466A (en) * | 2015-08-05 | 2015-10-07 | 王凯琳 | Medicine for treating vitiligo |
| CN110339257A (en) * | 2019-08-20 | 2019-10-18 | 江苏博润医疗集团有限公司 | It is a kind of for treating the external drug of leucoderma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101926857B (en) | Traditional Chinese medicinal liniment for treating vitiligo | |
| CN103816233A (en) | Externally-used traditional Chinese medicinal composition for treating incomplete vitiligo | |
| CN104721489A (en) | Chinese patent medicine for treating Parkinson disease and preparation method thereof | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN103948684A (en) | Externally-applied liniment for treating leucoderma | |
| CN104524133B (en) | A kind of Chinese medicine composition of the solid born of the same parents' beauty treatment of kidney tonifying | |
| CN104758567B (en) | A kind of Chinese medicine for treating vasculitis disease | |
| CN108686146A (en) | A kind of Dressed plaster promoting blood circulation and removing blood stasis and preparation method thereof | |
| CN110856731A (en) | Traditional Chinese medicine external navel treatment ointment formula and preparation method thereof | |
| CN106806445A (en) | A kind of Chinese medicine composition for treating leucoderma | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale | |
| CN101327281A (en) | Traditional Chinese medicine for treating facial paralysis caused by apoplexy | |
| CN103933336A (en) | Traditional Chinese medicine combination for treating leucoderma | |
| CN105521391A (en) | Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine | |
| CN104815132A (en) | External lotion for treating low back and leg pain and preparation method | |
| CN104208552A (en) | Chinese herba preparation for treating tetanus | |
| CN204411492U (en) | A kind of external application Chinese medicine bag for the treatment of lumbago | |
| CN104688901A (en) | Traditional Chinese medicine topical agent for preventing constipation of patients with acute myocardial infarction and nursing method | |
| CN104208433A (en) | Traditional Chinese medicine preparation for treating tinea of feet and hands | |
| CN103948764A (en) | Traditional Chinese medicine for treating edema during menstruation | |
| CN104042921A (en) | Traditional Chinese medicine composition for treating leucoderma | |
| CN103768359B (en) | A kind of Chinese medicine composition for the treatment of male sex's hyposexuality | |
| CN107308406A (en) | A kind of liniment of cure scapulohumeral periarthritis and preparation method thereof | |
| CN111214635A (en) | Pedicure powder for treating foot pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140528 |